Bijoyesh Mookerjee, MD

Contact Dr. Mookerjee

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Medical School
Armed Forces Medical College

Residency
SUNY at Brooklyn NY 1991 - 1994

Fellowship
National Cancer Institute 1994 - 1997
SUNY at Brooklyn NY 1989 - 1991

Board Certification
Medical Oncology
Internal Medicine

Hospital Appointment
Thomas Jefferson University Hospital

Hospital Appointment
Active Medical Staff

University Appointment
Assistant Professor of Medical Oncology

Research and Clinical Interests
Medical Oncology, Hematology-Oncology, Bone Marrow Transpant, Hematologic Malignancies, Leukemia, Lymphoma

Publications

Most recent Peer-reviewed Publications

1. Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: A double-blind, randomized phase III study (HORIZON III)
2. Cediranib monotherapy in patients with advanced renal cell carcinoma: Results of a randomised phase II study
3. A2-step approach to myeloablative haploidentical stem cell transplantation: A phase 1/2 trial performed with optimized T-cell dosing
4. Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease
5. Adenovirus DNA polymerase is recognized by human CD8+ T cells
6. Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy
7. T Cell Repertoire Complexity Is Conserved after LLME Treatment of Donor Lymphocyte Infusions
8. In vitro methods for generating highly purified EBV associated tumor antigen-specific T cells by using solid phase T cell selection system for immunotherapy
9. Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with Cidofovir
10. Cytoprotection in acute myelogenous leukemia (AML) therapy
11. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma
12. Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy
13. Overcoming drug resistan Targeting more than one site
14. Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM)
15. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB
16. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia- inducible factor 1α
17. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
18. p53-mediated repression of nuclear factor-κB RelA via the transcriptional integrator p300
19. Human herpes virus-6 encephalitis after bone marrow transplantation: Successful treatment with ganciclovir
20. Regulation of phosphoprotein p18 in leukemic cells: Cell cycle regulated phosphorylation by p34cdc2 kinase

View All Publications